Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2

Area of Science:

• Hepatology
• Mitochondrial Biology
• Molecular Medicine

Background:

• Ischemia-reperfusion (I/R) injury is a significant clinical problem.
• The mitochondrial permeability transition (MPT) is a key pathway mediating liver necrosis post-I/R.
• The role of specific kinases, like JNK2, in MPT-induced liver injury requires further elucidation.

Purpose of the Study:

• To investigate the role of c-Jun N-terminal kinase 2 (JNK2) in the pathogenesis of liver injury following I/R.
• To determine if JNK2 deficiency impacts MPT and subsequent hepatocellular damage.

Main Methods:

• Utilized wildtype (WT) and JNK2 knockout (KO) mouse models subjected to 70% liver ischemia for 1 hour followed by 8 hours of reperfusion.
• Assessed hepatocyte injury through alanine transaminase (ALT) levels and histological analysis of necrosis.
• Evaluated animal survival using Kaplan-Meier analysis and assessed mitochondrial function via intravital multiphoton microscopy with rhodamine 123.

Main Results:

• JNK2 KO mice exhibited significantly reduced ALT release (38% less) and histological evidence of necrosis (39% less) compared to WT mice.
• Survival rates were markedly improved in JNK2 KO mice (57% at 14 days vs. 11% in WT).
• Mitochondrial depolarization, indicative of MPT, was significantly lower in hepatocytes from JNK2 KO mice (43%) versus WT mice (82%) post-reperfusion.

Conclusions:

• JNK2 plays a critical role in mediating hepatocellular injury and death following I/R.
• JNK2 contributes to I/R-induced liver damage by promoting mitochondrial dysfunction via the MPT pathway.
• Targeting JNK2 may represent a therapeutic strategy to mitigate liver injury in I/R settings.